Inferensys

Glossary

PAMPA

The Parallel Artificial Membrane Permeability Assay (PAMPA) is a high-throughput, non-cell-based in vitro method used to model passive transcellular permeability, a key determinant of oral drug absorption.
ML engineer managing model versions on laptop, version history visible, technical Git-like workflow.
Parallel Artificial Membrane Permeability Assay

What is PAMPA?

A high-throughput in vitro method for modeling passive transcellular permeability, often integrated with in silico predictive models.

The Parallel Artificial Membrane Permeability Assay (PAMPA) is a high-throughput, non-cell-based in vitro method used to measure a compound's passive transcellular permeability. It models diffusion across a gastrointestinal tract or blood-brain barrier by quantifying the rate at which a molecule traverses an artificial lipid membrane infused into a porous filter support.

PAMPA data serves as a critical input for training Quantitative Structure-Property Relationship (QSPR) models, enabling rapid in silico screening of oral bioavailability. By providing a standardized, reproducible measurement of passive diffusion decoupled from active transport and metabolism, it directly informs ADMET prediction workflows and guides medicinal chemistry optimization.

PERMEABILITY ASSAY FUNDAMENTALS

Key Features of PAMPA

The Parallel Artificial Membrane Permeability Assay (PAMPA) is a critical high-throughput screening tool for predicting passive transcellular permeability. Understanding its core components is essential for interpreting in silico predictions.

01

The Artificial Membrane Barrier

PAMPA utilizes a lipid-infused artificial membrane—typically a mixture of phospholipids dissolved in an organic solvent like dodecane—coated onto a porous filter support. This creates a simplified, reproducible model of the intestinal epithelial bilayer. Unlike cell-based assays (e.g., Caco-2), it lacks active transporters and paracellular pores, isolating the passive transcellular diffusion mechanism. The lipid composition can be tuned; for example, a porcine brain lipid extract is used to model the Blood-Brain Barrier (BBB-PAMPA).

02

The Double-Sink Method

To maintain sink conditions and mimic in vivo absorption, a pH gradient and a scavenger are often employed. The donor compartment is typically buffered at pH 5.5–6.5, while the acceptor compartment is at pH 7.4. A surfactant or serum protein in the acceptor well binds permeated molecules, preventing back-diffusion. This 'double-sink' approach creates a unidirectional flux, ensuring the effective permeability (P_e) measurement reflects true absorption potential rather than an equilibrium state.

03

Permeability Calculation & Classification

The effective permeability (P_e) is calculated from the rate of compound appearance in the acceptor compartment, typically expressed in cm/s. Results are benchmarked against known standards:

  • High Permeability: P_e > 10 × 10⁻⁶ cm/s (e.g., verapamil)
  • Low Permeability: P_e < 1 × 10⁻⁶ cm/s (e.g., ranitidine) This binary classification directly informs the Biopharmaceutics Classification System (BCS) and correlates strongly with human oral absorption fraction.
04

Unstirred Water Layer (UWL) Correction

A critical artifact in PAMPA is the Unstirred Water Layer (UWL), a stagnant aqueous boundary adjacent to the membrane. For highly permeable lipophilic compounds, diffusion across the UWL becomes the rate-limiting step, causing an underestimation of true membrane permeability. Advanced protocols apply a pKa^{flux} correction or use vigorous stirring to minimize UWL thickness. In silico models trained on PAMPA data must account for this, often by incorporating Abraham solvation parameters to deconvolute UWL resistance from membrane resistance.

05

Correlation with In Silico Models

PAMPA data serves as a gold-standard training endpoint for Quantitative Structure-Property Relationship (QSPR) models. Key molecular descriptors used to predict PAMPA permeability include:

  • LogP/LogD: Partition coefficient as a measure of lipophilicity
  • Topological Polar Surface Area (TPSA): A proxy for hydrogen bonding capacity
  • Molecular Weight: Correlates inversely with diffusion coefficient Graph Neural Networks (GNNs) trained on PAMPA datasets can generalize beyond the Lipinski rule-of-five space, predicting permeability for macrocycles and PROTACs.
06

PAMPA vs. Caco-2 Assay

While both measure permeability, they provide distinct information:

  • PAMPA: Isolates passive transcellular transport. High-throughput, low cost, and highly reproducible.
  • Caco-2: A cell-based assay expressing active transporters (e.g., P-gp efflux) and tight junctions. It captures active uptake, efflux, and paracellular transport. A high PAMPA permeability but low Caco-2 permeability strongly suggests the compound is an efflux transporter substrate, a key liability flagged in drug discovery.
COMPARATIVE METHODOLOGY

PAMPA vs. Cell-Based Permeability Assays

A systematic comparison of the Parallel Artificial Membrane Permeability Assay against common cell-based monolayer techniques for modeling passive and active transcellular transport.

FeaturePAMPACaco-2MDCK

Membrane Composition

Artificial lipid/oil mixture on filter support

Human colon carcinoma monolayer

Madin-Darby canine kidney monolayer

Transport Mechanism Modeled

Passive transcellular only

Passive, active uptake, efflux, paracellular

Passive, active uptake, efflux, paracellular

Expression of Transporters

Expression of P-glycoprotein (P-gp)

Tight Junction Formation

Assay Throughput

Very High (> 1000 cmpds/week)

Medium (100-300 cmpds/week)

High (300-500 cmpds/week)

Typical Culture Time

None (artificial membrane)

21 days

3-7 days

Cost Per Data Point

$1-5

$20-50

$10-30

Correlation with Human Oral Absorption

High for passively absorbed drugs

Very High (gold standard)

High

Suitability for Discovery Screening

Excellent (primary screen)

Limited (secondary screen)

Good (secondary screen)

Mechanistic Deconvolution

Isolates passive permeability

Requires inhibitor studies

Requires inhibitor studies

PAMPA

Frequently Asked Questions

Explore the foundational concepts of the Parallel Artificial Membrane Permeability Assay, a critical high-throughput method for predicting passive transcellular permeability in drug discovery.

The Parallel Artificial Membrane Permeability Assay (PAMPA) is a high-throughput, non-cell-based in vitro method used to measure the passive, transcellular permeability of drug candidates. It works by creating an artificial lipid membrane infused with a lipophilic solvent, such as hexadecane or lecithin, on a porous filter support that separates a donor compartment from an acceptor compartment. The test compound is introduced into the donor well, and its concentration in the acceptor well is measured over time, typically via UV spectroscopy or LC-MS. The resulting effective permeability (Pe) is calculated from the flux rate, providing a direct measurement of a molecule's ability to diffuse through a passive lipid bilayer without the confounding influence of active transporters or paracellular routes.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.